menu
    • menu

    Company profile for Mineralys Therapeutics

    NEW Drugs in Dev: 2
    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    Arlanda is your partner for the Brazil market.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Mineralys Therapeutics is a private, clinical-stage biopharmaceutical company committed to developing best-in-class, novel therapy for the treatment of hypertension. We are driven to bring a targeted approach to the management of hypertension.At Mineralys Therapeutics we aim to redefine hypertension diagnosis, management and treatment. We are driven to break the “trial and failure” approach to hypertension management and b...
    Mineralys Therapeutics is a private, clinical-stage biopharmaceutical company committed to developing best-in-class, novel therapy for the treatment of hypertension. We are driven to bring a targeted approach to the management of hypertension.At Mineralys Therapeutics we aim to redefine hypertension diagnosis, management and treatment. We are driven to break the “trial and failure” approach to hypertension management and bring a personalized approach to the management of hypertension.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Mineralys TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    150 N. Radnor Chester Rd. Ste. F200 Radnor, PA 19087
    Telephone
    Telephone
    1-888-378-6240
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://mineralystx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/mineralys-therapeutics-inc/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Cosmoprof WW Bologna

    Cosmoprof WW Bologna

    Not Confirmed

    envelop Contact Supplier

    Cosmoprof WW Bologna

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Mineralys Therapeutics Names Jeffrey Munsie Chief Legal Officer
    Mineralys Therapeutics Names Jeffrey Munsie Chief Legal Officer

    24 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/24/3261150/0/en/Mineralys-Therapeutics-Appoints-Jeffrey-A-Munsie-as-Chief-Legal-Officer.html

    GLOBENEWSWIRE
    24 Mar 2026
    Share Share
    Mineralys Therapeutics Discloses Inducement Awards Per Nasdaq LR
    Mineralys Therapeutics Discloses Inducement Awards Per Nasdaq LR

    16 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/16/3256707/0/en/Mineralys-Therapeutics-Reports-Inducement-Awards-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    16 Mar 2026
    Share Share
    Mineralys Therapeutics Reports Q4 2025 Results and Business
    Mineralys Therapeutics Reports Q4 2025 Results and Business

    12 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/12/3255107/0/en/Mineralys-Therapeutics-Reports-Fourth-Quarter-2025-Financial-Results-and-Provides-Corporate-Update.html

    GLOBENEWSWIRE
    12 Mar 2026
    Share Share
    Mineralys Therapeutics Announces Q4 & FY 2025 Results, Hosts Call
    Mineralys Therapeutics Announces Q4 & FY 2025 Results, Hosts Call

    09 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/09/3251784/0/en/Mineralys-Therapeutics-to-Announce-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Host-Conference-Call-on-Thursday-March-12-2026.html

    GLOBENEWSWIRE
    09 Mar 2026
    Share Share
    Mineralys Therapeutics Discloses Inducement Awards Per Nasdaq LR
    Mineralys Therapeutics Discloses Inducement Awards Per Nasdaq LR

    26 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/26/3246086/0/en/Mineralys-Therapeutics-Reports-Inducement-Awards-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    26 Feb 2026
    Share Share
    Mineralys Therapeutics Reports Inducement Awards Under Nasdaq
    Mineralys Therapeutics Reports Inducement Awards Under Nasdaq

    11 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/12/3236800/0/en/Mineralys-Therapeutics-Reports-Inducement-Awards-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    11 Feb 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search